372 filings
Page 2 of 19
6-K
NYMXF
Nymox Pharmaceutical Corp
12 May 23
Current report (foreign)
4:52pm
NT 20-F
NYMXF
Nymox Pharmaceutical Corp
31 Mar 23
Notice of late annual filing (foreign)
4:16pm
6-K
NYMXF
Nymox Pharmaceutical Corp
6 Jan 23
Current report (foreign)
4:30pm
6-K/A
NYMXF
Nymox Pharmaceutical Corp
16 Nov 22
Current report (foreign) (amended)
12:23pm
6-K/A
NYMXF
Nymox Pharmaceutical Corp
16 Nov 22
Current report (foreign) (amended)
10:37am
6-K
NYMXF
Nymox Pharmaceutical Corp
14 Nov 22
Current report (foreign)
4:30pm
6-K
NYMXF
Nymox Pharmaceutical Corp
10 Nov 22
Current report (foreign)
6:24pm
6-K
NYMXF
Nymox Pharmaceutical Corp
15 Aug 22
Current report (foreign)
6:31am
6-K
NYMXF
Nymox Pharmaceutical Corp
7 Jul 22
Current report (foreign)
7:19pm
6-K
NYMXF
Nymox Pharmaceutical Corp
13 May 22
Current report (foreign)
5:14pm
4
NYMXF
Nymox Pharmaceutical Corp
6 May 22
NYMOX PHARMACEUTICAL / James George Robinson ownership change
6:00am
EFFECT
NYMXF
Nymox Pharmaceutical Corp
13 Apr 22
Notice of effectiveness
12:15am
CORRESP
NYMXF
Nymox Pharmaceutical Corp
6 Apr 22
Correspondence with SEC
12:00am
UPLOAD
NYMXF
Nymox Pharmaceutical Corp
4 Apr 22
Letter from SEC
12:00am
20-F
2021 FY
NYMXF
Nymox Pharmaceutical Corp
Annual report (foreign)
30 Mar 22
5:16pm
F-3
NYMXF
Nymox Pharmaceutical Corp
29 Mar 22
Shelf registration (foreign)
10:15am
6-K
NYMXF
Nymox Pharmaceutical Corp
22 Mar 22
Nymox Announces Closing of $6.4 Million Registered Direct Offering
4:43pm
424B5
NYMXF
Nymox Pharmaceutical Corp
22 Mar 22
Prospectus supplement for primary offering
2:56pm
EFFECT
NYMXF
Nymox Pharmaceutical Corp
31 Jan 22
Notice of effectiveness
12:15am